ArticleHaemophilia : the official journal of the World Federation of Hemophilia2020

Real-world data demonstrate improved bleed control and extended dosing intervals for patients with haemophilia B after switching to recombinant factor IX Fc fusion protein (rFIXFc) for up to 5 years.

Amy Shapiro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.